from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0060/-

LFCtreatmentdescriptionclass of inhibitor

-0.510

Amikacinug/mL Amikacintranslation

-0.437

Cap5-10ug/mL Capreomycintranslation

-0.642

Rox10-50 ug/mL Roxithromycintranslation

-0.879

SM2-5 ug/mL Streptomycintranslation

-0.977

Tet5-10 ug/mL Tetracyclinetranslation

-0.118

Rif0.2-5ug/mL Rifampicintranscription

-0.470

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.981

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.513

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.047

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.371

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.777

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.042

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.536

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.948

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.583

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.344

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.196

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.514

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.176

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.381

KCN5-20 ug/mL Potassium cyaniderespiration

-0.563

NaN30.2-2 mM Sodium aziderespiration

-0.121

Nigericin50 uM Nigericinrespiration

1.519

TRC10-150 ug/mL Triclosanrespiration

1.004

TRZ10-25 ug/mL Thioridazinerespiration

-1.647

Valinomycin0.5-10 uM Valinomycinrespiration

0.082

ZnSO42 mM ZnSO4respiration

0.289

menadione6-10 ug/mL Menadionerespiration

-1.087

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.580

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.347

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.666

NRP_1Non-replicating persistence stage 1dosRassociated

-0.270

Amp0.2mg/mL AmpicillincellWall

-0.489

Cephalexin20-100 ug/mL CephalexincellWall

-0.119

Cerulenin0.32-5 ug/mL CerulenincellWall

0.010

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.256

EMB10-20 ug/mL EthambutolcellWall

-0.875

Eta12-40 ug/mL EthionamidecellWall

-0.443

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.820

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.370

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.295

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.795

BZA0.12 mg/mL BenzamidearomaticAmides

1.078

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.926

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.154

H2O24 mM hydrogen peroxideDNAdamaging

0.478

Levo10 ug/mL LevofloxacinDNAdamaging

0.822

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.955

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.306

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.284

UVUV-irradiationDNAdamaging

-1.557

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.370

Antimycin12.5-50 ug/mL Antimycin A?

-0.216

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.633

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.407

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.582

PA8240.2-2 ug/mL PA-824?

-0.727

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.516

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.056

Verapamil50 uM Verapamil?

-0.054

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.221

methoxatin10-20 ug/mL Methoxatin?